Banka BioLoo share news, announcements and annual reports
NSE: BANKAConstructionSmall Cap
Banka BioLoo Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2018 · Issue price ₹31.55
Last close ₹61.46down ₹1.04 (1.66%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹62.50.
30 Oct: open ₹62.50, high ₹63.98, low ₹60.01
52-week range of traded prices to 30 Oct 2026
₹41.00Low, 30 Mar 2026₹96.58High, 3 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹67 Cr3,106th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 201.91
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 106.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.70
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 1.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.92
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,33287.0% delivered
Banka BioLoo share news and announcements
374 announcements, routine notices left out, newest first. Page 4 of 8.
Sep 2023
6 Sep · Legal
Exchange has sought clarification from Banka BioLoo Limited for the quarter ended 30-Jun-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Aug 2023
25 Aug · Board meeting
18 Aug · Board meeting
11 Aug · Updates
10 Aug · Board meeting
10 Aug · Results
Jul 2023
Jun 2023
May 2023
30 May · Results
30 May · Board meeting
Apr 2023
Feb 2023
27 Feb · Board meeting
24 Feb · Legal
Exchange has sought clarification from Banka BioLoo Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.22 Feb · Board meeting
13 Feb · Results
13 Feb · Board meeting
Jan 2023
Nov 2022
19 Nov · Related Party Transaction
Oct 2022
15 Oct · Legal
1 Oct · Management
Sep 2022
30 Sep · Meeting
7 Sep · Legal
Exchange has sought clarification from Banka BioLoo Limited with respect to announcement dated 03-Sep-2022 informing about Appointment.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.7 Sep · Legal
Exchange has sought clarification from Banka BioLoo Limited with respect to Financial Results dated 10-Aug-2022 for the period Jun, 2022On the basis of aforesaid disclosure, the Listed entity is required to clarify the following:1. Consolidated: Segment Reporting- Not found.The response of the company is awaited6 Sep · Meeting